Miracll ChemicalsLtd Future Growth
Future criteria checks 6/6
Miracll ChemicalsLtd is forecast to grow earnings and revenue by 80.2% and 59.3% per annum respectively. EPS is expected to grow by 80.5% per annum. Return on equity is forecast to be 22.5% in 3 years.
Key information
80.2%
Earnings growth rate
80.5%
EPS growth rate
Chemicals earnings growth | 38.4% |
Revenue growth rate | 59.3% |
Future return on equity | 22.5% |
Analyst coverage | Low |
Last updated | 10 Sep 2024 |
Recent future growth updates
No updates
Recent updates
The Returns On Capital At Miracll ChemicalsLtd (SZSE:300848) Don't Inspire Confidence
Dec 12Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt
Nov 16Miracll Chemicals Co.,Ltd (SZSE:300848) Stocks Shoot Up 41% But Its P/S Still Looks Reasonable
Oct 09Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden
Jul 13Miracll ChemicalsLtd (SZSE:300848) Has Announced A Dividend Of CN¥0.10
May 26Miracll Chemicals Co.,Ltd's (SZSE:300848) 26% Jump Shows Its Popularity With Investors
May 22Miracll ChemicalsLtd's (SZSE:300848) Anemic Earnings Might Be Worse Than You Think
Apr 29Market Participants Recognise Miracll Chemicals Co.,Ltd's (SZSE:300848) Earnings Pushing Shares 29% Higher
Mar 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,750 | 491 | N/A | 437 | 1 |
12/31/2025 | 3,722 | 254 | N/A | 319 | 1 |
12/31/2024 | 1,742 | 107 | N/A | -144 | 1 |
9/30/2024 | 1,591 | 69 | -974 | -166 | N/A |
6/30/2024 | 1,557 | 68 | -1,004 | -79 | N/A |
3/31/2024 | 1,543 | 77 | -921 | 21 | N/A |
12/31/2023 | 1,475 | 88 | -556 | 230 | N/A |
9/30/2023 | 1,426 | 100 | -632 | 178 | N/A |
6/30/2023 | 1,401 | 107 | -547 | 41 | N/A |
3/31/2023 | 1,402 | 112 | -330 | 102 | N/A |
1/1/2023 | 1,475 | 111 | -367 | 6 | N/A |
9/30/2022 | 1,561 | 124 | -215 | 89 | N/A |
6/30/2022 | 1,565 | 129 | -149 | 117 | N/A |
3/31/2022 | 1,416 | 119 | -178 | 79 | N/A |
1/1/2022 | 1,298 | 119 | -41 | 161 | N/A |
9/30/2021 | 1,152 | 119 | 129 | 163 | N/A |
6/30/2021 | 1,005 | 111 | 223 | 263 | N/A |
3/31/2021 | 915 | 115 | 181 | 213 | N/A |
12/31/2020 | 757 | 102 | 100 | 127 | N/A |
9/30/2020 | 985 | 123 | 23 | 55 | N/A |
6/30/2020 | 650 | 87 | -17 | 9 | N/A |
3/31/2020 | 625 | 77 | -10 | 18 | N/A |
12/31/2019 | 649 | 83 | 62 | 89 | N/A |
9/30/2019 | 320 | 33 | -1 | 27 | N/A |
6/30/2019 | 573 | 62 | -15 | 11 | N/A |
3/31/2019 | 582 | 59 | -25 | 3 | N/A |
12/31/2018 | 592 | 55 | -34 | -4 | N/A |
9/30/2018 | 589 | 52 | 18 | 46 | N/A |
6/30/2018 | 586 | 49 | N/A | 96 | N/A |
3/31/2018 | 556 | 47 | N/A | 103 | N/A |
12/31/2017 | 526 | 44 | N/A | 109 | N/A |
9/30/2017 | 480 | 40 | N/A | 99 | N/A |
6/30/2017 | 433 | 36 | N/A | 88 | N/A |
3/31/2017 | 384 | 32 | N/A | 80 | N/A |
12/31/2016 | 335 | 27 | N/A | 72 | N/A |
9/30/2016 | 293 | 26 | N/A | 55 | N/A |
6/30/2016 | 252 | 25 | N/A | 39 | N/A |
3/31/2016 | 236 | 21 | N/A | 26 | N/A |
12/31/2015 | 220 | 17 | N/A | 13 | N/A |
12/31/2014 | 162 | 3 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300848's forecast earnings growth (80.2% per year) is above the savings rate (2.8%).
Earnings vs Market: 300848's earnings (80.2% per year) are forecast to grow faster than the CN market (25.5% per year).
High Growth Earnings: 300848's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300848's revenue (59.3% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300848's revenue (59.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300848's Return on Equity is forecast to be high in 3 years time (22.5%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 08:51 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Miracll Chemicals Co.,Ltd is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhe Wang | Citic Securities Co., Ltd. |
Nan Xie | Zhongtai Securities Co. Ltd. |